(1548000) Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with targeted drugs: pooled analysis of clinical trials from the German CLL Study Group (GCLLSG).

Primary Author; Presenting Author(s)

• EB

  Elia Boccellato, MD

  Hematologist
  University Division of Hematology, A. O. U. Città della Salute e della Scienza di Torino, Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
  Torino, Piemonte, Italy

  Slides

Co-Author(s)

• AG

  Adam Giza, MSc

  ST
  Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne
  Cologne, Germany
• SR

  Sandra Robrecht, PhD

  Faculty of Medicine and University Hospital Cologne
  Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
  Cologne, Germany
• 

  Paula Cramer, MD

  Faculty of Medicine and University Hospital Cologne
  Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
  Cologne, Germany
• Jv

  Julia von Tresckow, MD

  Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen
  Essen, Germany
• 

  Othman Al-Sawaf, MD

  Faculty of Medicine
  University Hospital Cologne
  Cologne, Germany
• 

  Moritz Fürstenau, MD

  Faculty of Medicine and University Hospital Cologne
  Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
  Cologne, Germany
• 

  Eugen Tausch, MD

  Treating physician and research fellow
  Department of Internal Medicine III, Ulm University
  Ulm, Germany
• 

  Stephan Stilgenbauer, MD, PhD

  Department of Internal Medicine III, Ulm University
  Ulm, Germany
• 

  Kirsten Fischer, MD

  Faculty of Medicine and University Hospital Cologne
  Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
  Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf, University Hospital Cologne and University of Cologne
  Cologne, Germany
• 

  Barbara Eichhorst, MD

  Associate Professor, Consultant Hematologist
  University Hospital of Cologne
  Cologne, Germany
• CV

  Candida Vitale, MD, PhD

  Assistant Professor
  1 Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3,10126, Torino, Italy
  2 Department of Molecular Biotechnology and Health Sciences, University of Torino
  
  Torino, Italy
• MC

  Marta Coscia, MD, PhD

  Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3,10126, Torino, Italy2 Department of Molecular Biotechnology and Health Sciences, University of Torino
  Torino, Italy
• 

  Michael Hallek, MD

  Faculty of Medicine and University Hospital Cologne
  Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
  Cologne, Germany
• 

  Petra Langerbeins, MD

  Faculty of Medicine and University Hospital Cologne
  Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
  Cologne, Germany